Showing results (1-10 of 49) with videos related to
Sort By:
Pageof 5
Expert Opinion on Therapeutic Patents|February 22, 2014
CXCR2 modulators: a patent review (2009 - 2013)Michael P Dwyer, Younong YuCurrent Topics in Medicinal Chemistry|August 28, 2014
CXCR2 receptor antagonists: a medicinal chemistry perspectiveMichael P Dwyer, Younong YuBioorganic & Medicinal Chemistry Letters|February 7, 2009
Fluoroalkyl alpha side chain containing 3,4-diamino-cyclobutenediones as potent and orally bioavailable CXCR2-CXCR1 dual antagonistsPurakkattle Biju, Arthur G Taveras, Michael P Dwyer, et al.Current Topics in Medicinal Chemistry|June 12, 2010
Discovery of 3,4-diaminocyclobut-3-ene-1,2-dione-based CXCR2 receptor antagonists for the treatment of inflammatory disordersMichael P Dwyer, Purakattle BijuBioorganic & Medicinal Chemistry Letters|June 16, 2009
Diaminocyclobutenediones as potent and orally bioavailable CXCR2 receptor antagonists: SAR in the phenolic amide regionCynthia Aki, Jianping Chao, Johan A Ferreira, et al.Bioorganic & Medicinal Chemistry|March 12, 2003
Substituted dibenzo[c,h]cinnolines: topoisomerase I-targeting anticancer agentsYounong Yu, Sudhir K Singh, Angela Liu, et al.Journal of the American Chemical Society|May 16, 2018
Chemoselective Peptide Modification via Photocatalytic Tryptophan β-Position ConjugationYounong Yu, Li-Kang Zhang, Alexei V Buevich, et al.Bioorganic & Medicinal Chemistry Letters|February 10, 2009
3,4-Diamino-1,2,5-thiadiazole as potent and selective CXCR2 antagonistsPurakkattle Biju, Arthur G Taveras, Younong Yu, et al.Bioorganic & Medicinal Chemistry Letters|February 5, 2008
Synthesis and structure-activity relationships of heteroaryl substituted-3,4-diamino-3-cyclobut-3-ene-1,2-dione CXCR2/CXCR1 receptor antagonistsYounong Yu, Michael P Dwyer, Jianping Chao, et al.Pageof 5